Compounding pharmacies face new FDA guidance

2026-09-12 60 views 1 post

The FDA has issued new guidance affecting compounding pharmacies that make GLP-1 medications. Some may need to stop production if the drugs come off the shortage list. This could affect a lot of people getting affordable compounded sema/tirz. Anyone getting compounded meds — have you heard from your provider about this?